Drawing for UNIVERSAL DX

USPTO serial 90196723

UNIVERSAL DX

Reviewed by CopyMark Law Group

Reg. 6897887Status 700Registered
Filing date
Status date
Registration date
Nov 15, 2022
Examiner
MANCA, ALBERTO I
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with UNIVERSAL DX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jeffrey H. Handelsman

Jeffrey H. Handelsman Greenblum & Bernstein, P.L.C.1950 Roland Clarke PlaceReston, VA 20191-1411UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Diagnostic kits comprised of medical diagnostic reagents and assays for use in disease detection, namely, cancer and pre-cancer stagesACTIVE—
009Downloadable computer software, namely, software for diagnostic use in the field of cancer and pre-cancer stages prevention, screening, diagnosis and treatment; recorded computer software, namely, software for diagnostic use in the field of cancer and pre-cancer stages prevention, screening, diagnosis and treatmentACTIVE—
010Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the field of cancer and pre-cancer stages prevention, screening, diagnosis and treatmentACTIVE—
042Providing temporary use of non-downloadable software for the tracking of patient samples, from collection, shipment, storage, reception, preparation, and analysis, to test result, for use with metabolic testing in the field of cancer and pre-cancer stages; providing temporary use of non-downloadable software for the tracking of patient samples, from collection, shipment, storage, reception, preparation, and analysis, to test result, for use with medical testing in the field of cancer and pre-cancer stages; providing temporary use of non-downloadable software for use as a quality control system for metabolic testing in the field of cancer and pre-cancer stages; providing temporary use of non-downloadable software for use as a quality control system for medical testing in the field of cancer and pre-cancer stages; quality control services for others in the field of cancer and pre-cancer stages; metabolic testing quality control services; medical testing quality control services in the field of cancer and pre-cancer stages; providing online nondownloadable software to control and improve the reliability and quality of metabolic testing in the field of cancer and pre-cancer stages; providing online non-downloadable software to control and improve the reliability and quality of medical testing in the field of cancer and pre-cancer stages; software as a service (SAAS) services featuring software for analyzing and reporting metabolic testing data in the field of cancer and pre-cancer stages; software as a service (SAAS) services featuring software for analyzing and reporting medical testing data in the field of cancer and pre-cancer stages; providing online non-downloadable computer software, namely, software for diagnostic use in the field of cancer and pre-cancer stages prevention, screening, diagnosis and treatmentACTIVE—
044Medical diagnostic testing, monitoring and reporting services in the field of cancer and pre-cancer stages; providing medical advisory, information and consulting services in the field of metabolic testing, namely, in the field of cancer and pre-cancer stages; providing medical advisory, information and consulting services in the field of medical testing, namely, in the field of cancer and pre-cancer stagesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 31, 2024ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Nov 15, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Nov 15, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 30, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 30, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 10, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 26, 2022OTHECASE RETURNED TO EXAMINATION—
Jul 22, 2022IUCNNOTICE OF ALLOWANCE CANCELLED—
Jul 18, 2022ATRQATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED—
Jul 18, 2022PCBGPETITION TO DIRECTOR - CHANGE BASIS - GRANTED—
Jul 18, 2022APETASSIGNED TO PETITION STAFF—
Jun 23, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 21, 2022EX1GSOU EXTENSION 1 GRANTED—
Jun 21, 2022EXT1SOU EXTENSION 1 FILED—
Jun 21, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 21, 2022TPADTEAS PETITION TO AMEND BASIS RECEIVED—
Dec 21, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 26, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 26, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 6, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 22, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 22, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Sep 22, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 22, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 22, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 11, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 10, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 10, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 18, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 18, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 18, 2021ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Mar 18, 2021EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Mar 18, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 18, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 18, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 11, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 11, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 11, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 5, 2021DOCKASSIGNED TO EXAMINER—
Feb 5, 2021DOCKASSIGNED TO EXAMINER—
Oct 29, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 19, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Oct 19, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 19, 2020ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Oct 19, 2020EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Oct 19, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 19, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 19, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Sep 24, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance